⚠ BETA β€” all market data shown (deals, filings, prices, indices) is demo / illustrative, not live trading data. For evaluation only; verify before acting.
June 16, 2026

NSE

Laurus Labs LimitedLAURUSLABS

LAURUSLABSβ‚Ή1,376.4β–Ό 0.67% today
Nifty Midcap 150

Laurus Labs is an API and CDMO company.

Key productsAPIs (ARV leadership), formulations, CDMO and bio.
GeographyIndia serving global.
CompetitorsDivi's, global API/CDMO.

AI-generated overview β€” verify before relying on it.

Net institutional flow

No institutional deals

Institutional buyers

0 in / 0 out

High-impact filings

0 Β· tilt Neutral

Next corporate action

Interim Dividend - Rs 1.20 Per Share

ex 2026-05-08

Competitive landscape β€” the read

vs mapped peers
Institutional money is backing CIPLA hardest (+β‚Ή1,527.1 Cr net). LAURUSLABS ranks #3 of 9 on flow (net buying +β‚Ή0 Cr). Filing momentum favours SUNPHARMA (+2). News & social buzz is most positive on DRREDDY.
#CompanyInst. flow β‚ΉCrDealsHi-impactFiling mom.BuzzNews
1CIPLA+β‚Ή1,527.1 Cr39β€”+1+1134
2ALKEM+β‚Ή103.5 Cr33β€”β€”-26
3LAURUSLABSThis+β‚Ή0 Cr2β€”β€”β€”β€”
4DRREDDY+β‚Ή0 Cr4β€”β€”+1532
5SUNPHARMA+β‚Ή0 Cr6β€”+2+929
6TORNTPHARM+β‚Ή0 Cr2β€”β€”β€”β€”
7LUPIN+β‚Ή0 Cr4β€”β€”β€”β€”
8ZYDUSLIFE+β‚Ή0 Cr1β€”β€”β€”β€”
9AUROPHARMA+β‚Ή0 Cr2β€”β€”β€”β€”

Ranked by net institutional flow (buys βˆ’ sells, β‚ΉCr). Filing momentum = bullish βˆ’ bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.

Timeline β€” LAURUSLABS day by day

Merged from deals, filings, corporate actions and news β€” newest first. Scope the deal/action portion with the period chips below.

Filings that matter

Bulk & block deals

No bulk/block deals for LAURUSLABS in this window.

Results & transcripts

News & chatter on LAURUSLABS

RSS News

0

No recent news.

Google News RSS β€” links open the source.

The Dispatch

0

No articles yet.

Our coverage.

Reddit

0

No Reddit chatter.

r/ posts mentioning the company.

Twitter / X

0

No posts.

Posts mentioning the company.